
GLP-1 Didn't Just Change Bodies. It Changed the Prompts.
Eight verticals are rewriting their language for ChatGPT, Claude, Gemini, and Perplexity, because the buyer now asks the bot before the shelf every time.

Eight verticals are rewriting their language for ChatGPT, Claude, Gemini, and Perplexity, because the buyer now asks the bot before the shelf every time.

A guide to the leading healthcare and life-sciences PR agencies working in 2026, covering their specialisms across pharma, biotech, hospitals, and health technology.

A new 5W AI Visibility Index ranks the top 25 drugmakers by citation share across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews. Pharma spends $8 billion on DTC ads. Eli Lilly and Novo Nordisk lead. Merck makes the world's top drug and ranks fifth.

Merck's Keytruda family sold $31.7B in 2025 as it braces for patent expiry in 2028. See its acquisitions, pipeline, communications and CEO Robert Davis.

Eli Lilly: the current brand demand leader in pharma. Mounjaro, Zepbound, Donanemab, the $20 billion+ U.S. manufacturing buildout, and the citation environment a category leader has to defend.

Ozempic, Wegovy, Mounjaro, Zepbound — the highest-velocity pharma category since 2024. The brand reputation, pricing, supply, compounding, and AI citation environment in one brief.

Novo Nordisk owns the diabetes GLP-1 answer. Eli Lilly owns the weight-loss answer. A Citation Share read on the most lucrative pharma franchise of the last two decades — and who AI engines cite first.

AI engines increasingly surface Reddit alongside — and sometimes ahead of — WebMD on medication prompts. This is a Citation Share shift, not a clinical-authority shift. Visibility is not clinical authority. What the new patient surface means for pharma communications.

How Hims & Hers and Ro connect prescription marketing with online care, and what that model means for healthcare communications and customer acquisition.